Final answer:
Atomoxetine and clonidine are better options for treating ADHD in patients with Tourette's syndrome, with clonidine often being the preferred choice.
Step-by-step explanation:
Among the options provided for treating attention deficit hyperactivity disorder (ADHD) in a patient with Tourette's syndrome, atomoxetine and clonidine are considered better choices compared to traditional stimulants. Stimulants like amphetamines and methylphenidate, though effective for ADHD, can exacerbate tics in patients with Tourette's syndrome. Atomoxetine, a selective norepinephrine reuptake inhibitor, and clonidine, an alpha-2 adrenergic agonist, are less likely to increase tics and can be beneficial for both ADHD and Tourette's symptoms. In clinical practice, clonidine is typically the preferred option as it has shown efficacy in reducing tics as well as addressing ADHD symptoms.